Literature DB >> 11796375

Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.

Kensuke Nagai1, Peter C Appelbaum, Todd A Davies, Linda M Kelly, Dianne B Hoellman, Arjana Tambic Andrasevic, Liga Drukalska, Waleria Hryniewicz, Michael R Jacobs, Jana Kolman, Jolanta Miciuleviciene, Marina Pana, Lena Setchanova, Marianne Konkoly Thege, Helena Hupkova, Jan Trupl, Pavla Urbaskova.   

Abstract

Among 1,011 recently isolated Streptococcus pyogenes isolates from 10 Central and Eastern European centers, the MICs at which 50% of isolates are inhibited (MIC(50)s) and the MIC(90)s were as follows: for telithromycin, 0.03 and 0.06 microg/ml, respectively; for erythromycin, azithromycin, and clarithromycin, 0.06 to 0.125 and 1 to 8 microg/ml, respectively; and for clindamycin, 0.125 and 0.125 microg/ml, respectively. Erythromycin resistance occurred in 12.3% of strains. Erm(A) [subclass erm(TR)] was most commonly encountered (60.5%), followed by mef(A) (23.4%) and erm(B) (14.5%). At <0.5 microg/ml, telithromycin was active against 98.5% of the strains tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796375      PMCID: PMC127072          DOI: 10.1128/AAC.46.2.546-549.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.

Authors:  J C De Azavedo; R H Yeung; D J Bast; C L Duncan; S B Borgia; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.

Authors:  T A Davies; L M Kelly; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Detection of erythromycin resistance by the polymerase chain reaction using primers in conserved regions of erm rRNA methylase genes.

Authors:  M Arthur; C Molinas; C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

4.  Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe--a multicenter study with use of standardized methods.

Authors:  P C Appelbaum; C Gladkova; W Hryniewicz; B Kojouharov; D Kotulova; F Mihalcu; J Schindler; L Setchanova; N Semina; J Trupl; S Tyski; P Urbaskova; M R Jacobs
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

5.  Macrolide resistance in group A streptococci.

Authors:  D Savoia; C Avanzini; K Bosio; G Volpe; D Carpi; G Dotti; M Zucca
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

6.  Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.

Authors:  P E Varaldo; E A Debbia; G Nicoletti; D Pavesio; S Ripa; G C Schito; G Tempera
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

7.  High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.

Authors:  J I Alós; B Aracil; J Oteo; C Torres; J L Gómez-Garcés
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

8.  Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients.

Authors:  E Bingen; F Fitoussi; C Doit; R Cohen; A Tanna; R George; C Loukil; N Brahimi; I Le Thomas; D Deforche
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

9.  In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.

Authors:  P Bemer-Melchior; M E Juvin; S Tassin; A Bryskier; G C Schito; H B Drugeon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more
  12 in total

1.  Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.

Authors:  Young Uh; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

2.  Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.

Authors:  C Silva-Costa; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

Authors:  Pamela McGhee; Catherine Clark; Klaudia M Kosowska-Shick; Kensuke Nagai; Bonifacio Dewasse; Linda Beachel; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

4.  Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors:  Glenn A Pankuch; Gengrong Lin; Dianne B Hoellman; Caryn E Good; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.

Authors:  Catherine Clark; Pamela McGhee; Peter C Appelbaum; Klaudia Kosowska-Shick
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

6.  In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.

Authors:  Hiroyuki Sugiyama; Ippei Yoshida; Mayumi Ueki; Katsuhiko Tanabe; Akira Manaka; Keiichi Hiramatsu
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

7.  Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.

Authors:  Meredith E Hasenbein; John E Warner; Kathleen G Lambert; Sarah E Cole; Andrew B Onderdonk; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Evidence of a conjugal erythromycin resistance element in the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Charlene R Jackson; Julie A Boylan; Jonathan G Frye; Frank C Gherardini
Journal:  Int J Antimicrob Agents       Date:  2007-10-01       Impact factor: 5.283

9.  Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Chun-Ming Lee; Wen-Kuei Huang; Tsu-Lan Wu; Jen-Hsien Wan; Dine Yang; Jainn-Ming Shyr; Yin-Ching Chuang; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.

Authors:  Roman S Kozlov; Tatiana M Bogdanovitch; Peter C Appelbaum; Lois Ednie; Leonid S Stratchounski; Michael R Jacobs; Bülent Bozdogan
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.